Silo Pharma, Inc.
PublicSilo Pharma, Inc. is now publicly traded
The data on this page reflects Silo Pharma, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Jul 9, 2026
Total Funding Raised
$10.57M
Company Overview
Silo Pharma, Inc. is a biopharmaceutical company that develops novel therapeutics and drug delivery systems for underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system diseases.
AI Layer
Application
Keywords
Silo Pharma, Inc. Comparables
Compare Silo Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CAD Therapeutics, Inc. | 63% | |
| Ella LeRoy Corporation | 60% |
For institutional investors. Book with your work email.
Silo Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jul 9, 2026 | ||||
| Private Placement | Jul 18, 2024 | ||||
| Private Placement | Feb 12, 2021 |
For institutional investors. Book with your work email.
Silo Pharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.